CPHI Milan 2026 to bring 260+ pharma leaders together, launch sustainability summit
The three-day event will bring together pharmaceutical manufacturers, biotech companies, regulators, consultants, suppliers and technology innovators
The three-day event will bring together pharmaceutical manufacturers, biotech companies, regulators, consultants, suppliers and technology innovators
The transaction is expected to close in Q4 2026, subject to applicable Indian regulatory requirements and customary closing conditions
The company invested Rs. 642 crore in R&D during the quarter, representing 8% of revenues, while organic capex stood at Rs. 585 crore
The roughly 600,000-square-foot campus at Generation Park will be designed to grow and adapt for decades
Revenue from operations rose to Rs. 2,229 crore in Q1 FY27 from Rs. 1,901 crore a year earlier
Revenue from operations surged 37.1% year-on-year (YoY) to Rs. 756.3 crore in Q1 FY27
The company reported operating revenue of Rs. 1,167 crore in Q1 FY27
The portfolio includes both oncology and non-oncology products, covering vials, lyophilised formulations, ampoules and pre-filled syringes
The investment will support Biodeal’s expansion across Asian markets while accelerating its growth across the CIS, Latin America, Africa and Europe
Evotec is eligible for milestone payments tied to the successful delivery of validated hit series for each target. The companies did not disclose financial terms
The authorisation is supported by the Phase III REMIX-1 and REMIX-2 trials,
The collaborations with Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree and smartQare broaden Philips’ wearable and out-of-hospital monitoring capabilities
Profit before exceptional items and tax stood at Rs. 510 million, while profit after exceptional items and tax was Rs. 507 million during the quarter.
LifeCell and Shraddha Diagnostics plan to expand their diagnostic services across state, providing clinicians and patients with access to a broader range of diagnostic capabilities
REVAHALE is the first and only LAMA currently available in India that combines once-daily dosing with nebulised administration, offering an additional treatment option for COPD patients
Revenue from operations rose 12% YoY to Rs. 554 crore
Sumitomo Pharma says the report contains assertions about its operations and accounting that are “clearly inconsistent with the facts
Beyond water quality monitoring, E-Eye can also analyse toxicants in environmental and biological samples, vegetables, food products, tea, herbal products, soil and milk
Subscribe To Our Newsletter & Stay Updated